Choice of an initial antiretroviral regimen in the resource-limited setting: the cost of virologic failure.
Campbell
Thomas B
TB
Division of Infectious Diseases, Department of Medicine, University of Colorado Denver, Denver, CO 80262, USA. thomas.campbell@uchsc.edu
D019380:Anti-HIV Agents / Q000627:therapeutic use*; D003906:Developing Countries; D024882:Drug Resistance, Viral; D015658:HIV Infections / Q000188:drug therapy*; D006801:Humans; D017211:Treatment Failure
D019380:Anti-HIV Agents